Osborn Williams & Donohoe LLC lessened its holdings in McKesson Co. (NYSE:MCK) by 43.7% during the 4th quarter, Holdings Channel reports. The firm owned 4,479 shares of the company’s stock after selling 3,472 shares during the period. Osborn Williams & Donohoe LLC’s holdings in McKesson were worth $699,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. Ingalls & Snyder LLC increased its position in McKesson by 76.7% in the third quarter. Ingalls & Snyder LLC now owns 16,939 shares of the company’s stock worth $2,602,000 after purchasing an additional 7,352 shares during the last quarter. Whittier Trust Co. increased its position in McKesson by 1.5% in the third quarter. Whittier Trust Co. now owns 62,812 shares of the company’s stock worth $9,649,000 after purchasing an additional 898 shares during the last quarter. River & Mercantile Asset Management LLP increased its position in McKesson by 278.6% in the third quarter. River & Mercantile Asset Management LLP now owns 177,824 shares of the company’s stock worth $27,321,000 after purchasing an additional 130,852 shares during the last quarter. Synovus Financial Corp increased its position in McKesson by 62.8% in the third quarter. Synovus Financial Corp now owns 5,803 shares of the company’s stock worth $890,000 after purchasing an additional 2,238 shares during the last quarter. Finally, Cypress Capital Management LLC increased its position in McKesson by 77.4% in the second quarter. Cypress Capital Management LLC now owns 3,861 shares of the company’s stock worth $635,000 after purchasing an additional 1,684 shares during the last quarter. Institutional investors own 87.84% of the company’s stock.
McKesson Co. (NYSE MCK) traded up $2.23 during mid-day trading on Monday, reaching $172.59. 668,342 shares of the company’s stock were exchanged, compared to its average volume of 1,666,085. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.05 and a quick ratio of 0.61. McKesson Co. has a fifty-two week low of $133.82 and a fifty-two week high of $173.84. The company has a market capitalization of $35,990.00, a PE ratio of 8.18, a price-to-earnings-growth ratio of 1.74 and a beta of 1.23.
McKesson (NYSE:MCK) last posted its quarterly earnings data on Thursday, October 26th. The company reported $3.28 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.78 by $0.50. The business had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.69 billion. McKesson had a net margin of 2.24% and a return on equity of 24.87%. The business’s revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.94 earnings per share. equities research analysts forecast that McKesson Co. will post 12.26 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, January 2nd. Stockholders of record on Friday, December 1st were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.79%. The ex-dividend date was Thursday, November 30th. McKesson’s payout ratio is presently 6.44%.
Several equities research analysts recently weighed in on MCK shares. Needham & Company LLC set a $178.00 price target on shares of McKesson and gave the stock a “buy” rating in a research report on Tuesday, October 24th. Credit Suisse Group restated an “underperform” rating and issued a $130.00 price target (down previously from $155.00) on shares of McKesson in a research report on Thursday, November 9th. Deutsche Bank started coverage on shares of McKesson in a research report on Monday, December 4th. They issued a “buy” rating and a $175.00 price target on the stock. Royal Bank of Canada reiterated a “hold” rating and set a $170.00 price objective on shares of McKesson in a research report on Friday, October 27th. Finally, Zacks Investment Research upgraded shares of McKesson from a “hold” rating to a “buy” rating and set a $177.00 price objective on the stock in a research report on Tuesday, December 26th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and ten have given a buy rating to the stock. McKesson currently has a consensus rating of “Hold” and an average target price of $174.85.
In other news, Chairman John H. Hammergren sold 65,000 shares of the company’s stock in a transaction dated Thursday, December 14th. The shares were sold at an average price of $160.00, for a total value of $10,400,000.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.20% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was originally published by Stock Observer and is the property of of Stock Observer. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.thestockobserver.com/2018/01/22/osborn-williams-donohoe-llc-trims-position-in-mckesson-co-mck.html.
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.